Petlife Pharmaceuticals, Inc. engages in the research, development, sales, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases. Its products include preventative, tabs, and pet foods under the brand name Vitalzul. The company was founded on June 26, 2014 and is headquartered in Hancock, MD.
Company profile
Ticker
PTLF, GEUR
Exchange
Website
CEO
Sebastian Serrell-Watts
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Aztek Ventures Inc., Eco Ventures Group, Inc., Genesis Uranium Corp., Modern Renewable Technologies, Inc., Vault Technology, Inc.
SEC CIK
Corporate docs
IRS number
331133537
PTLF stock data
Latest filings (excl ownership)
8-K
Other Events
30 Jan 20
8-K
Completion of Acquisition or Disposition of Assets
16 Jan 20
15-12G
Securities registration termination
16 Oct 19
10-Q
2018 Q2
Quarterly report
17 Jul 18
NT 10-Q
Notice of late quarterly filing
17 Jul 18
8-K
Entry into a Material Definitive Agreement
6 Jun 18
PRE 14C
Preliminary information
27 Apr 18
NT 10-Q
Notice of late quarterly filing
17 Apr 18
8-K
Entry into a Material Definitive Agreement
29 Mar 18
8-K
Departure of Directors or Certain Officers
28 Mar 18
Latest ownership filings
SC 13D/A
PetLife Pharmaceuticals, Inc.
7 May 18
3
De Leon Castro Laura
27 Apr 18
4
Vyvyan Campbell
20 Mar 18
4
Ramana Vivek
2 Mar 18
4
Ralph T Salvagno
2 Mar 18
3
Ramana Vivek
2 Mar 18
4
Vyvyan Campbell
2 Mar 18
SC 13D/A
PetLife Pharmaceuticals, Inc.
25 Jul 17
SC 13D
PetLife Pharmaceuticals, Inc.
7 Apr 17
4
Ralph T Salvagno
27 Mar 17